Medicaid spending and utilization for central nervous system drugs

Health Care Financing Review

Volumn 26, Issue 1, 2004, Pages 57-73

  Baugh, David K ^a,b   Pine, Penelope L ^a   Blackwell, Steve ^a   Ciborowski, Gary ^a  

^a The Centers for Medicare Medicaid Services (CMS)   (United States)

^b Center for Medicare and Medicaid Services   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; HYPNOTIC SEDATIVE AGENT; NEUROLEPTIC AGENT;

CENTRAL NERVOUS SYSTEM DISEASE; COST BENEFIT ANALYSIS; DATA BASE; DISABILITY; DRUG COST; FEE FOR SERVICE DATA BASE; HEALTH CARE COST; HEALTH CARE UTILIZATION; HUMAN; MEDICAID; MEDICAL FEE; MENTAL DEFICIENCY; POPULATION RESEARCH; PRESCRIPTION; REVIEW; STATE MEDICAID RESEARCH FILE; STATISTICAL ANALYSIS; UNITED STATES;

ADOLESCENT; ADULT; AGED; CENTRAL NERVOUS SYSTEM AGENTS; CHILD; DRUG UTILIZATION REVIEW; FEE-FOR-SERVICE PLANS; HUMANS; MEDICAID; MIDDLE AGED; STATE HEALTH PLANS; UNITED STATES;

EID: 11044231957     PISSN: 01958631     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (3)

1. Baugh, D., Pine, P., Blackwell, S., et al.: Medicaid Prescription Drug Spending in the 1990s: A Decade of Change. Health Care Financing Review 25(3):5-23, Fall 2004.
2. Centers for Medicare & Medicaid Services: Internet address: http://cms.hhs.gov/researchers/max (Accessed December 2003).
3. Wolters Kluwer Health: Internet address: http://www.Medi-Span.com/ products/product_mddb.asp (Accessed May 2003).